USD10
TERN Shares
About Terns PharmaTerns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
USD10
TERN Shares
About Terns PharmaTerns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$5.98B
OPEN PRICE
$53.04
LOW (1Y)
$1.87
HIGH (1Y)
$53.19
LOW (24H)
$52.91
HIGH (24H)
$53.08
VOLUME (24H)
$7.92M
59.76%
Price history
Time | Price | Change |
|---|---|---|
Today | $53.04 | |
1 Day | $52.92 | |
1 Week | $49.73 | |
1 Month | $42.12 | |
1 Year | $2.76 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
